tDCS as an Adjuvant to Intensive Speech Therapy for Chronic Post Stroke Aphasia
Transcranial Direct Current Stimulation (tDCS) an Adjuvant to Intensive Speech Therapy in Chronic Post Stroke Aphasia
Sponsor: Austin Speech Labs
Listed as NCT02801864, this NA trial focuses on Aphasia and Language and remains ongoing. Sponsored by Austin Speech Labs, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jul 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Jul 2019 [monthly]
Enrolling By Invitation NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Austin Speech Labs
- Burke Medical Research Institute
- University of Texas
For direct contact, visit the study record on ClinicalTrials.gov .